ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services... Show more
a manufacturer of semiconductors and provides IC testing services
Industry Semiconductors
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BLUC | 30.61 | 0.03 | +0.09% |
| Bluemonte Large Cap Core ETF | |||
| SMOX | 30.24 | 0.01 | +0.03% |
| Horizon Small/Mid Cap Core Equity ETF | |||
| XISE | 30.44 | N/A | N/A |
| FT Vest US Eq Buf & Prm IncETF-Sept | |||
| QQQX | 29.45 | -0.05 | -0.15% |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | |||
| PSF | 19.41 | -0.09 | -0.46% |
| COHEN & STEERS SELECT PREFERRED AND Income FUND | |||
A.I.dvisor indicates that over the last year, IMOS has been loosely correlated with IPGP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IMOS jumps, then IPGP could also see price increases.
| Ticker / NAME | Correlation To IMOS | 1D Price Change % | ||
|---|---|---|---|---|
| IMOS | 100% | -0.42% | ||
| IPGP - IMOS | 42% Loosely correlated | -2.18% | ||
| ASX - IMOS | 41% Loosely correlated | -0.79% | ||
| VECO - IMOS | 40% Loosely correlated | -6.14% | ||
| ENTG - IMOS | 40% Loosely correlated | -2.15% | ||
| LRCX - IMOS | 40% Loosely correlated | -4.46% | ||
More | ||||
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IMOS advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .
IMOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 250 cases where IMOS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on July 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMOS as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IMOS turned negative on July 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
IMOS moved below its 50-day moving average on July 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.510) is normal, around the industry mean (15.404). P/E Ratio (71.046) is within average values for comparable stocks, (217.225). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.625). Dividend Yield (0.014) settles around the average of (0.015) among similar stocks. P/S Ratio (2.476) is also within normal values, averaging (41.720).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.